Check-Cap Overview

  • Year Founded
  • 2005

Year Founded

  • Status
  • Public

  • Employees
  • 85

Employees

  • Stock Symbol
  • CHEK

Stock Symbol

  • Investments
  • 1

  • Share Price
  • $0.86
  • (As of Friday Closing)

Check-Cap General Information

Description

Check-Cap Ltd is a clinical-stage medical diagnostics company engaged in the development of an ingestible imaging capsule that utilizes low-dose X-rays for the detection and imaging of colonic polyps and colorectal cancers, or CRC. The company is developing C-Scan, the first capsule-based system for preparation-free, colorectal cancer screening. Its scanning capsule will be swallowed and propelled by natural motility through the gastrointestinal tract and excreted naturally with no need for retrieval for data collection. The operations of the company are presently located in Israel, but it currently expects to market products in the United States, Europe, Israel and Japan.

Contact Information

Ownership Status
Publicly Held
Financing Status
Formerly VC-backed
Corporate Office
  • 29 Abba Hushi Avenue
  • PO Box 1271
  • Isfiya 3009000
  • Israel
+972
Primary Industry
Diagnostic Equipment
Stock Exchange
NAS
Vertical(s)
Life Sciences, Oncology
Corporate Office
  • 29 Abba Hushi Avenue
  • PO Box 1271
  • Isfiya 3009000
  • Israel
+972

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Check-Cap Stock Performance

As of 14-Feb-2025, Check-Cap’s stock price is $0.86. Its current market cap is $5.04M with 5.85M shares.

(As of Friday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$0.86 $0.90 $0.56 - $3.45 $5.04M 5.85M 1.31M -$2.14

Check-Cap Financials Summary

As of 30-Jun-2024, Check-Cap has a trailing 12-month revenue of null.

In Thousands,
USD
TTM 30-Jun-2024 FY 2023 31-Dec-2023 FY 2022 31-Dec-2022 FY 2021 31-Dec-2021
EV (12,999) (15,869) (31,797) 9,745
Revenue 0 0 0 0
EBITDA (13,820) (19,113) (19,739) (17,085)
Net Income (12,560) (17,568) (19,108) (17,202)
Total Assets 18,090 25,017 45,441 55,659
Total Debt 0 0 964 1,145
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Check-Cap Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Check-Cap‘s full profile, request access.

Request a free trial

Check-Cap Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Check-Cap Ltd is a clinical-stage medical diagnostics company engaged in the development of an ingestible imaging capsul
Diagnostic Equipment
Isfiya, Israel
85 As of 2022

San Diego, CA
 

Seoul, South Korea
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Check-Cap Competitors (7)

One of Check-Cap’s 7 competitors is QuidelOrtho, a Corporation company based in San Diego, CA.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
QuidelOrtho Corporation San Diego, CA
IntroMedic Formerly PE-Backed Seoul, South Korea
Atmo Biosciences Venture Capital-Backed Box Hill, Australia
Insightec Venture Capital-Backed Tirat Carmel, Israel
Abingdon Health Formerly VC-backed York, United Kingdom
You’re viewing 5 of 7 competitors. Get the full list »

Check-Cap Patents

Check-Cap Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
EP-4228494-A1 Machine learning system for x-ray based imaging capsule Inactive 31-Dec-2020
US-20240020828-A1 Machine learning system for x-ray based imaging capsule Pending 31-Dec-2020
EP-4087488-A1 Radiation capsule for bowel disease imaging and localize drug delivery Pending 06-Jan-2020
US-20220395242-A1 Radiation capsule for bowel disease imaging and localize drug delivery Pending 06-Jan-2020
EP-4087488-A4 Radiation capsule for bowel disease imaging and localize drug delivery Pending 06-Jan-2020 A61B6/4057
To view Check-Cap’s complete patent history, request access »

Check-Cap Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Check-Cap Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Check-Cap‘s full profile, request access.

Request a free trial

Check-Cap Acquisitions (1)

Check-Cap’s most recent deal was a Reverse Merger with Nobul. The deal was made on 25-Mar-2024.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Nobul 25-Mar-2024 Reverse Merger Real Estate Services (B2C)
To view Check-Cap’s complete acquisitions history, request access »

Check-Cap FAQs

  • When was Check-Cap founded?

    Check-Cap was founded in 2005.

  • Where is Check-Cap headquartered?

    Check-Cap is headquartered in Isfiya, Israel.

  • What is the size of Check-Cap?

    Check-Cap has 85 total employees.

  • What industry is Check-Cap in?

    Check-Cap’s primary industry is Diagnostic Equipment.

  • Is Check-Cap a private or public company?

    Check-Cap is a Public company.

  • What is Check-Cap’s stock symbol?

    The ticker symbol for Check-Cap is CHEK.

  • What is the current stock price of Check-Cap?

    As of 14-Feb-2025 the stock price of Check-Cap is $0.86.

  • What is the current market cap of Check-Cap?

    The current market capitalization of Check-Cap is $5.04M.

  • Who are Check-Cap’s competitors?

    QuidelOrtho, IntroMedic, Atmo Biosciences, Insightec, and Abingdon Health are some of the 7 competitors of Check-Cap.

  • What is Check-Cap’s annual earnings per share (EPS)?

    Check-Cap’s EPS for 12 months was -$2.14.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »